Loading insider details...
Latest Form 4 (Nov 13, 2026): Purchase of 12,333 NXTC shares, $62.9K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 13, 2026 | NextCure, Inc. (NXTC) | Purchase | 12,333 | $62.9K |
| Nov 10, 2026 | InMed Pharmaceuticals Inc. (MTRI) | Purchase | 2,640 | $34.6K |
| Nov 9, 2026 | NextCure, Inc. (NXTC) | Purchase | 1,024 | $5.2K |
| Oct 27, 2026 | NextCure, Inc. (NXTC) | Purchase | 5,626 | $27.2K |
| Oct 27, 2026 | InMed Pharmaceuticals Inc. (INM) | Purchase | 4 | $5.28 |
| Oct 21, 2026 | TENAX THERAPEUTICS, INC. (TENX) | Purchase | 336,528 | $507.0K |
| Oct 20, 2026 | InMed Pharmaceuticals Inc. (INM) | Purchase | 1 | $1.32 |
| Oct 15, 2026 | InMed Pharmaceuticals Inc. (INM) | Purchase | 564 | $750.12 |
| Oct 8, 2026 | InMed Pharmaceuticals Inc. (INM) | Purchase | 5,601 | $7.4K |
| Oct 5, 2026 | InMed Pharmaceuticals Inc. (INM) | Purchase | 16,431 | $21.8K |